We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Tissue Engineering for Craniofacial Reconstruction

By Biotechdaily staff writers
Posted on 10 Apr 2007
Tissue engineering has emerged as a promising option for the reconstitution of lost or damaged organs and tissues, avoiding the complications associated with traditional transplants.

Tissue engineers attempt to repair or regenerate damaged tissue by using engineered tissue replacements that can maintain functionality during regeneration and ultimately integrate into the host tissue. More...
The conventional tissue-engineering prototype combines isolated cells with suitable bioactive agents in a biomaterial scaffold. It is widely recognized that scaffold architecture can deeply influence the behavior of cells on tissue-engineering constructs.

During the 85th General Session of the International Association for Dental Research, held in March 2007 in New Orleans, LA, USA, scientists from the University of Durham (UK) presented their study's findings reporting on high internal phase emulsion (HIPE) polymerization, which offers tremendous control of scaffold morphology. HIPEs can be readily molded into the irregular shapes frequently needed in craniofacial reconstruction and cured in situ to a rigid foam.

The investigators demonstrated that emulsion templating could be used to generate rigid, biodegradable scaffolds with interconnected pores. These scaffolds are of particular interest in craniofacial tissue engineering, because of the rigidity of the resulting foams and the ease of fabrication.


Related Links:
University of Durham

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
HPV Test
Allplex HPV28 Detection
New
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Plasma pTau217 testing can predict future amyloid accumulation and cognitive decline in cognitively healthy older adults (photo courtesy of Shutterstock)

Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read more

Industry

view channel
Image: Pathlight combines WGS and dPCR to identify and longitudinally track large‑scale genomic changes, known as structural variants (photo courtesy of SAGA Diagnositcs)

Roche Affiliate Expands MRD Portfolio with SAGA Acquisition

Foundation Medicine, Inc., an independent affiliate of Roche, announced plans to expand its monitoring portfolio with SAGA Diagnostics’ Pathlight, a personalized, tumor-informed molecular residual disease... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.